Ultrasonic Drug Delivery – A General Review. Pitt, W. G., Husseini, G. A., & Staples, B. J. Expert opinion on drug delivery, 1(1):37--56, November, 2004. ![Ultrasonic Drug Delivery – A General Review [link]](https://bibbase.org/img/filetypes/link.svg "link")
Paper doi abstract bibtex Ultrasound (US) has an ever-increasing role in the delivery of therapeutic agents including genetic material, proteins, and chemotherapeutic agents. Cavitating gas bodies such as microbubbles are the mediators through which the energy of relatively non-interactive pressure waves is concentrated to produce forces that permeabilize cell membranes and disrupt the vesicles that carry drugs. Thus the presence of microbubbles enormously enhances delivery of genetic material, proteins and smaller chemical agents. Delivery of genetic material is greatly enhanced by ultrasound in the presence of microbubbles. Attaching the DNA directly to the microbubbles or to gas-containing liposomes enhances gene uptake even further. US-enhanced gene delivery has been studied in various tissues including cardiac, vascular, skeletal muscle, tumor and even fetal tissue. US-enhanced delivery of proteins has found most application in transdermal delivery of insulin. Cavitation events reversibly disrupt the structure of the stratus corneum to allow transport of these large molecules. Other hormones and small proteins could also be delivered transdermally. Small chemotherapeutic molecules are delivered in research settings from micelles and liposomes exposed to ultrasound. Cavitation appears to play two roles: it disrupts the structure of the carrier vesicle and releases the drug; it also makes the cell membranes and capillaries more permeable to drugs. There remains a need to better understand the physics of cavitation of microbubbles and the impact that such cavitation has upon cells and drug-carrying vesicles.
@article{pitt_ultrasonic_2004,
title = {Ultrasonic {Drug} {Delivery} – {A} {General} {Review}},
volume = {1},
issn = {1742-5247},
url = {http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1361256/},
doi = {10.1517/17425247.1.1.37},
abstract = {Ultrasound (US) has an ever-increasing role in the delivery of therapeutic agents including genetic material, proteins, and chemotherapeutic agents. Cavitating gas bodies such as microbubbles are the mediators through which the energy of relatively non-interactive pressure waves is concentrated to produce forces that permeabilize cell membranes and disrupt the vesicles that carry drugs. Thus the presence of microbubbles enormously enhances delivery of genetic material, proteins and smaller chemical agents. Delivery of genetic material is greatly enhanced by ultrasound in the presence of microbubbles. Attaching the DNA directly to the microbubbles or to gas-containing liposomes enhances gene uptake even further. US-enhanced gene delivery has been studied in various tissues including cardiac, vascular, skeletal muscle, tumor and even fetal tissue. US-enhanced delivery of proteins has found most application in transdermal delivery of insulin. Cavitation events reversibly disrupt the structure of the stratus corneum to allow transport of these large molecules. Other hormones and small proteins could also be delivered transdermally. Small chemotherapeutic molecules are delivered in research settings from micelles and liposomes exposed to ultrasound. Cavitation appears to play two roles: it disrupts the structure of the carrier vesicle and releases the drug; it also makes the cell membranes and capillaries more permeable to drugs. There remains a need to better understand the physics of cavitation of microbubbles and the impact that such cavitation has upon cells and drug-carrying vesicles.},
number = {1},
urldate = {2016-06-22TZ},
journal = {Expert opinion on drug delivery},
author = {Pitt, William G. and Husseini, Ghaleb A. and Staples, Bryant J.},
month = nov,
year = {2004},
pmid = {16296719},
pmcid = {PMC1361256},
pages = {37--56}
}
Downloads: 0
{"_id":"AXJFQybKpBsMnCeb7","bibbaseid":"pitt-husseini-staples-ultrasonicdrugdeliveryageneralreview-2004","downloads":0,"creationDate":"2016-10-19T06:57:25.120Z","title":"Ultrasonic Drug Delivery – A General Review","author_short":["Pitt, W. G.","Husseini, G. A.","Staples, B. J."],"year":2004,"bibtype":"article","biburl":"http://bibbase.org/zotero/clinique.alizes","bibdata":{"bibtype":"article","type":"article","title":"Ultrasonic Drug Delivery – A General Review","volume":"1","issn":"1742-5247","url":"http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1361256/","doi":"10.1517/17425247.1.1.37","abstract":"Ultrasound (US) has an ever-increasing role in the delivery of therapeutic agents including genetic material, proteins, and chemotherapeutic agents. Cavitating gas bodies such as microbubbles are the mediators through which the energy of relatively non-interactive pressure waves is concentrated to produce forces that permeabilize cell membranes and disrupt the vesicles that carry drugs. Thus the presence of microbubbles enormously enhances delivery of genetic material, proteins and smaller chemical agents. Delivery of genetic material is greatly enhanced by ultrasound in the presence of microbubbles. Attaching the DNA directly to the microbubbles or to gas-containing liposomes enhances gene uptake even further. US-enhanced gene delivery has been studied in various tissues including cardiac, vascular, skeletal muscle, tumor and even fetal tissue. US-enhanced delivery of proteins has found most application in transdermal delivery of insulin. Cavitation events reversibly disrupt the structure of the stratus corneum to allow transport of these large molecules. Other hormones and small proteins could also be delivered transdermally. Small chemotherapeutic molecules are delivered in research settings from micelles and liposomes exposed to ultrasound. Cavitation appears to play two roles: it disrupts the structure of the carrier vesicle and releases the drug; it also makes the cell membranes and capillaries more permeable to drugs. There remains a need to better understand the physics of cavitation of microbubbles and the impact that such cavitation has upon cells and drug-carrying vesicles.","number":"1","urldate":"2016-06-22TZ","journal":"Expert opinion on drug delivery","author":[{"propositions":[],"lastnames":["Pitt"],"firstnames":["William","G."],"suffixes":[]},{"propositions":[],"lastnames":["Husseini"],"firstnames":["Ghaleb","A."],"suffixes":[]},{"propositions":[],"lastnames":["Staples"],"firstnames":["Bryant","J."],"suffixes":[]}],"month":"November","year":"2004","pmid":"16296719","pmcid":"PMC1361256","pages":"37--56","bibtex":"@article{pitt_ultrasonic_2004,\n\ttitle = {Ultrasonic {Drug} {Delivery} – {A} {General} {Review}},\n\tvolume = {1},\n\tissn = {1742-5247},\n\turl = {http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1361256/},\n\tdoi = {10.1517/17425247.1.1.37},\n\tabstract = {Ultrasound (US) has an ever-increasing role in the delivery of therapeutic agents including genetic material, proteins, and chemotherapeutic agents. Cavitating gas bodies such as microbubbles are the mediators through which the energy of relatively non-interactive pressure waves is concentrated to produce forces that permeabilize cell membranes and disrupt the vesicles that carry drugs. Thus the presence of microbubbles enormously enhances delivery of genetic material, proteins and smaller chemical agents. Delivery of genetic material is greatly enhanced by ultrasound in the presence of microbubbles. Attaching the DNA directly to the microbubbles or to gas-containing liposomes enhances gene uptake even further. US-enhanced gene delivery has been studied in various tissues including cardiac, vascular, skeletal muscle, tumor and even fetal tissue. US-enhanced delivery of proteins has found most application in transdermal delivery of insulin. Cavitation events reversibly disrupt the structure of the stratus corneum to allow transport of these large molecules. Other hormones and small proteins could also be delivered transdermally. Small chemotherapeutic molecules are delivered in research settings from micelles and liposomes exposed to ultrasound. Cavitation appears to play two roles: it disrupts the structure of the carrier vesicle and releases the drug; it also makes the cell membranes and capillaries more permeable to drugs. There remains a need to better understand the physics of cavitation of microbubbles and the impact that such cavitation has upon cells and drug-carrying vesicles.},\n\tnumber = {1},\n\turldate = {2016-06-22TZ},\n\tjournal = {Expert opinion on drug delivery},\n\tauthor = {Pitt, William G. and Husseini, Ghaleb A. and Staples, Bryant J.},\n\tmonth = nov,\n\tyear = {2004},\n\tpmid = {16296719},\n\tpmcid = {PMC1361256},\n\tpages = {37--56}\n}\n\n","author_short":["Pitt, W. G.","Husseini, G. A.","Staples, B. J."],"key":"pitt_ultrasonic_2004","id":"pitt_ultrasonic_2004","bibbaseid":"pitt-husseini-staples-ultrasonicdrugdeliveryageneralreview-2004","role":"author","urls":{"Paper":"http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1361256/"},"downloads":0},"search_terms":["ultrasonic","drug","delivery","general","review","pitt","husseini","staples"],"keywords":[],"authorIDs":[],"dataSources":["zrHLXSbQqWNoePjKt"]}